Home Healthcare Biotechnology Non-invasive Cancer Diagnostics Market

Non-invasive Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Pathology-based Instruments, Imaging Instruments, Kits & Reagents, Consumables), By Technology (Imaging, Liquid Biopsy, Immunoassay), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Cervical Cancer, Skin Cancer, Others), By End Use (Hospitals, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 20, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
  7. North America Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
  8. Europe Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
  9. APAC Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
  10. Middle East and Africa Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
  11. LATAM Non-invasive Cancer Diagnostics Market Size Analysis
    1. Introduction
    2. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Pathology-based Instruments
        1. PCR Instruments
        2. NGS Instruments
        3. Microarrays
      3. Imaging Instruments
        1. Magnetic Resonance Imaging
        2. Computed Tomography
        3. Mammography
        4. Others
      4. Kits & Reagents
      5. Consumables
    3. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Imaging
      2. Liquid Biopsy
      3. Immunoassay
    4. Non-invasive Cancer Diagnostics Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Blood Cancer
      6. Liver Cancer
      7. Cervical Cancer
      8. Skin Cancer
      9. Others
    5. Non-invasive Cancer Diagnostics Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Pathology-based Instruments
          1. PCR Instruments
          2. NGS Instruments
          3. Microarrays
        3. Imaging Instruments
          1. Magnetic Resonance Imaging
          2. Computed Tomography
          3. Mammography
          4. Others
        4. Kits & Reagents
        5. Consumables
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Imaging
        2. Liquid Biopsy
        3. Immunoassay
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Lung Cancer
        2. Breast Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Blood Cancer
        6. Liver Cancer
        7. Cervical Cancer
        8. Skin Cancer
        9. Others
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
  12. Competitive Landscape
    1. Non-invasive Cancer Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Roche Diagnostics (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina, Inc. (US)
    3. Thermo Fisher Scientific Inc. (US)
    4. QIAGEN N.V. (Germany)
    5. Agilent Technologies, Inc. (US)
    6. bioMérieux S.A. (France)
    7. Guardant Health, Inc. (US)
    8. Exact Sciences Corporation (US)
    9. GE HealthCare (US)
    10. Siemens Healthineers AG (Germany)
    11. Koninklijke Philips N.V. (Netherlands)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.